Skip to main content

American Association for Cancer Research® (AACR) Annual Meeting 2025

27-30 April 2025
Image
lc_lab_image_with_lab_coat-1200x800-5b2df79.jpg


Connect with Labcorp at the American Association for Cancer Research (AACR) Annual Meeting

April 27-30, 2025 | Chicago, IL | Booth 2054

Save the date for our spotlight theater

  • Date: Sunday, April 27th
  • Time:1:30 - 2:30 PM
  • Location: Spotlight Theater A/B/C
Schedule a meeting


Sunday, April 27 2:00 PM - 5:00 PM

Presenting AuthorTitleLocationDetails
Grant Hogg​Orthogonal confirmation using the PacBio Two step Universal adapter Amplicon protocol to validate a comprehensive genomic profiling assay for hematologic malignancies​Location: Poster section 29​
Poster Board Number: 12​
Track: Clinical Research ​
Session: Diagnostic Biomarkers 2​
Published Abstract Number:  679
Jennifer B Jackson, Ph.D.Comprehensive genomic profiling of cell-free DNA and matched white blood cells improves accuracy of ctDNA molecular response in immunotherapy treated NSCLCLocation: Poster section 31​
Poster Board Number: 11​
Track: Clinical Research​
Session: Predictive Biomarkers 2​
Published Abstract Number: 726


 


Monday, April 28 9:00 AM - 12:00 PM

Presenting AuthorTitleLocationDetails
Sarabjot PablaHigh TLR3 transcript levels correlate with high TIM3 and VISTA checkpoints, but not with outcome after immune checkpoint blockadeLocation: Poster section 31​
Poster Board Number: 13​
Track: Clinical Research​
Session: Predictive Biomarkers 3​
Published Abstract Number: 2044 


 


Monday, April 28 2:00 PM - 5:00 PM

Presenting AuthorTitleLocationDetails
Kobina A Amoah, PharmD, MBAPharmacogenomic Landscape of UGT1A1 in Cancer Patients from the Avera Sequencing and Analytics Protocol (ASAP) RegistryLocation: Poster section 34​
Poster Board Number: 21​
Track: Clinical Research
Session: RWD: Clinico-Genomics​
Published Abstract Number:  3401
Mark Sausen, PhDMultiomics model reveals the main biological features independent of tumor size that influence ctDNA shedding in colon cancerLocation: Poster section 29​
Poster Board Number: 24
Track: Clinical Research 
Session: Liquid Biopsy: Circulating Nucleic Acids 1
Published Abstract Number: 3259


 


Tuesday, April 29 2:00 PM - 5:00 PM

Presenting AuthorTitleLocationDetails
Sherri Barnes, Ph.D.Increasing translatability of syngeneic mouse models of cancer through the application of human-validated, clinically relevant gene expression-based measurements of the tumor immune microenvironmentLocation: Poster section 3​
Poster Board Number: 14​
Track: Tumor Biology​
Session: Models of Cancer and Mechanisms​
Published Abstract Number: 5166
David Draper, Ph.D.A new 30-color spectral flow cytometry panel for T cell characterizationLocation: Poster section 16​
Poster Board Number: 13​
Track:  Experimental and Molecular Therapeutics​
Session: Drug Discovery Assay Technologies​
Published Abstract Number: 5485
Hussein Chehade, Ph.D.From 2D to 3D: Advancing Preclinical Platforms in Cancer ModelsLocation: Poster section 16​
Poster Board Number:  6 
Track: Experimental and Molecular Therapeutics
Session: Drug Discovery Assay Technologies​
Published Abstract Number: 5478
Mark Sausen, PhDMEDOCC-CrEATE trial update: Feasibility of measuring circulating tumor DNA post-surgery to guide adjuvant chemotherapy in stage II colon cancer patientsLocation: Poster section 46 ​
Poster Board Number:  CT221
Session: Phase II Clinical Trials 2
Published Abstract Number: CT221


 


Wednesday, April 30 9:00 AM - 12:00 PM

Presenting AuthorTitleLocationDetails
Amy Meltzer, B.A.Deep Dive into the Performance of Structural Variants Reported by PGDx elio plasma focus DxLocation: Poster section 10​
Poster Board Number: 9​
Track: Molecular/Cellular Biology and Genetics
Session: Genomic Profiling of Tumors 3​
Published Abstract Number: 6628
Jiahua Zhao, Ph.D. FACMGMutational Profiles of Pancreatic Cancer Patients from Eastern Asia Using Somatic Exome SequencingLocation: Poster section 45​
Poster Board Number:  16​
Track:  Bioinformatics/Computational Biology/Systems Biology/Convergent Science​
Session: Identification of New Cancer Vulnerabilities Through Convergence Science​
Published Abstract Number: 7471
Anita J. Zaitouna, Ph.D.Multi-modal assessment of an anti-HER2 (Trastuzumab) antibody-drug conjugate screening assay for breast cancer modelsLocation: Poster section 16​
Poster Board Number: 12​
Session Category: Experimental and Molecular Therapeutics​
Session Title: Antibody-Based Cancer Therapeutics 4​
Published Abstract Number: 6746
Justin SniderModel characterization and tumor immune profile assessment of syngeneic Renca murine renal cell carcinoma in female BALB/c.Location: Poster section 5​
Poster Board Number: 18​
Session Category: Tumor Biology​
Session Title: The Soil Matters: Tumor Microenvironment Complexity and Targeting​
Published Abstract Number: 6556


Not affiliated with or endorsed by AACR